Your article was successfully shared with the contacts you provided.
Big pharma was one of many powerful interest groups that President Trump promised to bring to heel during his 2016 campaign. The self-proclaimed master negotiator described drug prices, like health care in general, as out of control because feeble political leaders had either been bought or bullied by drug-makers.
So far, Trump’s tough talk hasn’t been matched by tough action. He has dropped any talk of allowing Medicare to negotiate drug prices, one of many proposals he floated during his campaign.
Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.
Your access to unlimited BenefitsPRO.com content isn’t changing. Once you are an ALM digital member, you’ll receive:
Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
61% of employers surveyed consider caregiving benefits to be a top priority for their business and employees, yet 22% consider themselves as below average in developing caregiving benefits. Download this info sheet to help your clients remain competitive by offering a care benefit package.